The Longevity Week: Addressing global Longevity

A packed week of multidisciplinary events with a global focus on the Longevity challenge.

One year ago, the first Longevity Forum event was held in London. Its main objective: To facilitate the exchange of ideas between experts from the fields of science and social science to explore the opportunities presented by increases in human longevity. The brainchild of founders Jim Mellon, Andrew Scott and Dafina Grapci-Penney, the forum was created as a place where cutting-edge ideas would be generated, debated and critiqued.

This year, with a growing network of individuals and organisations spanning the worlds of government, business, finance, research, academia and NGOs across sectors and countries, it was felt more time was needed to address all the multidisciplinary topics connected to global Longevity. So, for 2019, the scope of the Forum has been expanded to include a full week of events focused on helping people achieve longer, healthier and more fulfilled lives: The Longevity Week.

The theme of The Longevity Week is Longevity 2030 – a deeper dive into the ideas and innovations that will shape humanity in the next 10 years. The week’s events will explore a wide range of subjects, including:

  • The ever-expanding boundaries of science and technology
  • The economic opportunities presented by longevity and implications for governments and individuals
  • The policy agenda supporting educational, healthcare and social care systems to ensure they are fit for the future
  • The relationship between humans and machines, and the governance framework needed to ensure that this growing interdependence can help humans achieve their full potential

Key Highlights

On Monday, Andrew Scott presents a kick-off event in Singapore The Global Longevity Agenda, which is one of The Longevity Forum’s flagship initiatives and developed in conjunction with the Stanford Center on Longevity. There he will discuss the findings of an initiative, which outlined the principles that make longevity distinct from aging, and set high level objectives which governments around the world need to achieve in the next 10 years to support the longevity agenda.

On Tuesday, at Oriel College in Oxford, Jim Mellon welcomes delegates to the Science Summit, which brings together leading experts in the field of longevity research to discuss their most recent findings with fellow researchers, investors and entrepreneurs working in the field. Meanwhile, at Kings College in London, the International Longevity Policy and Governance Summit will host the world’s first international, cross-border, cross-sector summit on the current state of international Longevity policy and governance.

The centrepiece of The Longevity Week is Thursday’s Annual Longevity Form. The forum is a full day of discussion involving a wide range of speakers from many different disciplines and countries, all focused how to achieve a step change in both the policy and attitudes which are required for societies to reap a significant longevity dividend and maximise the return on Longevity. Key speakers at this year’s annual forum include Dr Nir Barzilai, Founding Director of the Institute for Aging at The Albert Einstein College of Medicine, Andy Briggs, Co-Chair of the new UK Longevity Council, and Dr Linda Fried, Dean of the Mailman School of Public Health at Columbia University, and many more.


Longevity.Technology’s editor in chief, Philip Newman, will be in attendance at several of the Longevity Week events. If you’d like to connect with him next week, be sure to get in touch.

Danny Sullivan
Contributing Editor Danny has worked in technology communications for more than 15 years, spanning Europe and North America. From bionics and lasers to software and pharmaceuticals – and everything in between – he’s covered it all. Danny has wide experience of technology publishing and technical writing and has specific interest in the transfer from idea to market.

Latest articles

114 year-old cells converted to pluripotent stem cells

AgeX publishes evidence of supercentenarian cellular age reversal: new paper supports hypothesis of no upper age limit for reprogramming cellular aging. This is big...

Placenta blood and personalised Longevity therapies

The placenta is a reservoir of stem cells with minimal ethical concerns. The establishment of placental stem cell biobanks will enable their use in...

Anti-aging drugs in MIT’s 10 Breakthrough Technologies 2020

For the last 20 years MIT Technology Review's Breakthrough Technologies 2020 has been assessing the way we live, work and invest.  Back in 2001, MIT...

Proving the Longevity potential of NAD+

Talking sirtuins, NAD+ and trials with Elysium Health CEO Eric Marcotulli. When it comes to the world of consumer anti-aging supplements, there are few higher-profile...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.